Stocks
Genesco Financial Statements (GCO) |
||||||||||
| Genescosmart-lab.ru | % | 2024Q2 | 2024Q3 | 2024Q3 | 2024Q4 | 2024Q4 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 07.09.2023 | 31.10.2023 | 07.12.2023 | 31.01.2024 | 27.03.2024 | 27.03.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 523.0 | 579.3 | 579.3 | 739.0 | 739.0 | 2 637 | |||
| Operating Income, bln rub | -38.6 | 10.9 | 10.9 | 38.5 | 38.5 | 98.7 | ||||
| EBITDA, bln rub | ? | -10.1 | 10.8 | 10.8 | 45.4 | 52.5 | 119.5 | |||
| Net profit, bln rub | ? | -31.7 | 6.54 | 6.54 | 27.2 | 27.2 | 67.5 | |||
| OCF, bln rub | ? | 35.3 | 1.60 | 118.3 | 119.9 | |||||
| CAPEX, bln rub | ? | 18.1 | 14.4 | 10.6 | 25.0 | |||||
| FCF, bln rub | ? | 17.2 | -12.8 | 107.8 | 94.9 | |||||
| Dividend payout, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | ||||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0 | ||||
| OPEX, bln rub | 259.5 | 267.5 | 267.5 | 303.5 | 303.5 | 1 142 | ||||
| Cost of production, bln rub | 273.5 | 300.9 | 300.9 | 396.9 | 396.9 | 1 396 | ||||
| R&D, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Interest expenses, bln rub | 2.38 | 2.21 | 2.21 | 1.54 | 1.54 | 7.49 | ||||
| Assets, bln rub | 1 495 | 1 493 | 1 493 | 1 330 | 1 330 | 1 330 | ||||
| Net Assets, bln rub | ? | 533.0 | 537.0 | 537.0 | 571.2 | 571.2 | 571.2 | |||
| Debt, bln rub | 672.3 | 650.4 | 650.4 | 522.9 | 526.2 | 526.2 | ||||
| Cash, bln rub | 37.4 | 21.7 | 21.7 | 35.2 | 35.2 | 35.2 | ||||
| Net debt, bln rub | 634.9 | 628.7 | 628.7 | 487.8 | 491.1 | 491.1 | ||||
| Ordinary share price, rub | 27.8 | 27.4 | 25.9 | 27.8 | 28.8 | 27.0 | ||||
| Number of ordinary shares, mln | 11.3 | 10.9 | 10.9 | 10.9 | 10.9 | 10.9 | ||||
| Market cap, bln rub | 315 | 299 | 282 | 303 | 314 | 294 | ||||
| EV, bln rub | ? | 950 | 927 | 911 | 791 | 805 | 785 | |||
| Book value, bln rub | 495 | 537 | 501 | 571 | 534 | 534 | ||||
| EPS, rub | ? | -2.79 | 0.60 | 0.60 | 2.49 | 2.49 | 6.18 | |||
| FCF/share, rub | 1.52 | 0.00 | -1.18 | 0.00 | 9.88 | 8.70 | ||||
| BV/share, rub | 43.7 | 49.3 | 46.0 | 52.4 | 49.0 | 49.0 | ||||
| EBITDA margin, % | ? | -1.94% | 1.86% | 1.86% | 6.15% | 7.11% | 4.53% | |||
| Net margin, % | ? | -6.05% | 1.13% | 1.13% | 3.68% | 3.68% | 2.56% | |||
| FCF yield, % | ? | -19.2% | 7.96% | 1.56% | -4.24% | 30.2% | 32.3% | |||
| ROE, % | ? | -19.0% | -9.36% | -9.36% | 1.51% | 11.8% | 11.8% | |||
| ROA, % | ? | -6.76% | -3.37% | -3.37% | 0.65% | 5.07% | 5.07% | |||
| P/E | ? | -3.11 | -5.94 | -5.62 | 35.2 | 4.66 | 4.36 | |||
| P/FCF | -5.21 | 64.1 | -23.6 | 3.31 | 3.10 | |||||
| P/S | ? | 0.16 | 0.14 | 0.13 | 0.13 | 0.12 | 0.11 | |||
| P/BV | ? | 0.64 | 0.56 | 0.56 | 0.53 | 0.59 | 0.55 | |||
| EV/EBITDA | ? | -14.4 | 707.9 | 695.4 | 13.9 | 6.74 | 6.57 | |||
| Debt/EBITDA | -9.64 | 479.9 | 479.9 | 8.58 | 4.11 | 4.11 | ||||
| R&D/CAPEX, % | 0.00% | 0.00% | 0.00% | 0 | ||||||
| CAPEX/Revenue, % | 3.45% | 0.00% | 2.49% | 0.00% | 1.43% | 0.95% | ||||
| Genesco shareholders | ||||||||||
